Researchers Uncover Dual Role of p53 in Blood Vessel Growth

The protein p53, often referred to as the “guardian of the genome” due to its crucial role in cancer prevention, has been found to influence blood vessel growth in complex ways. A team of researchers at Karolinska Institutet has revealed that the activity levels of p53 can either slow or damage blood vessels, depending on the intensity of its response. This research was published on January 2, 2026, in the journal Cell Death & Disease.

Investigating p53’s Impact on Blood Vessel Cells

In their study, the researchers explored how variations in p53 levels affect the behavior of endothelial cells, which are critical for the formation of new blood vessels. By employing a new class of compounds to modulate p53 levels and utilizing advanced imaging techniques, the team was able to observe cellular responses during angiogenesis, the process of new vessel formation.

During angiogenesis, specialized cells in the blood vessel walls must divide, migrate, and assemble to create new vessels. However, in conditions such as cancer and certain eye diseases, this growth can become uncontrolled, exacerbating these conditions.

According to Pavitra Kannan, a researcher at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet, the study revealed a significant sensitivity of blood vessel cells to varying levels of p53. “One of the most striking observations was how sensitive these blood vessel cells are even to very low p53 levels compared to other cell types,” Kannan stated.

Contrasting Effects of p53 Levels

The research indicates that lower levels of p53 cause endothelial cells to temporarily halt division, while elevated levels of p53 lead to permanent changes where these cells can neither divide nor survive. This duality illustrates how a single protein can yield contrasting cellular outcomes based on its activation levels.

Despite these divergent responses, both low and high p53 levels were found to inhibit blood vessel growth. This finding underscores the complexity of p53’s role in vascular biology and highlights its potential as a target for therapeutic interventions aimed at controlling abnormal vessel growth in diseases like cancer and certain ocular conditions.

The implications of this research extend beyond basic biology, offering insights into potential treatments for conditions characterized by abnormal angiogenesis. As noted in the study by Omayma Al-Radi and colleagues, understanding the pharmacological activation of p53 may pave the way for novel strategies to address these pressing health issues.

For further details, the study can be accessed through the journal Cell Death & Disease, DOI: 10.1038/s41419-025-08292-7.